| Quarterly Financials | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
Revenue  | 399 | 426 | 425 | 437 | 484 | 555 | 441 | 557 | 539 | 628 | 437 | 533 | 602 | 712 | 607 | 623 | 654 | 773 | 660 | 784 | 803 | 1,017 | 832 | 932 | 883 | 933 | 840 | 908 | 962 | 1,037 | 892 | 926 | 933 | 1,059 |
| Expenses | 262 | 280 | 297 | 292 | 327 | 374 | 300 | 325 | 366 | 403 | 297 | 364 | 408 | 443 | 430 | 464 | 438 | 508 | 472 | 552 | 555 | 680 | 596 | 663 | 626 | 600 | 620 | 646 | 660 | 674 | 668 | 711 | 779 | 739 |
| EBITDA | 138 | 146 | 128 | 145 | 158 | 181 | 142 | 231 | 174 | 225 | 140 | 170 | 193 | 269 | 177 | 160 | 216 | 265 | 188 | 232 | 248 | 337 | 236 | 268 | 257 | 333 | 220 | 261 | 302 | 363 | 224 | 215 | 154 | 320 |
| Operating Profit % | 33 % | 32 % | 27 % | 30 % | 30 % | 30 % | 29 % | 30 % | 30 % | 34 % | 30 % | 30 % | 30 % | 33 % | 28 % | 24 % | 32 % | 33 % | 27 % | 28 % | 29 % | 32 % | 26 % | 27 % | 27 % | 35 % | 22 % | 27 % | 30 % | 34 % | 24 % | 22 % | 15 % | 29 % |
| Depreciation | 35 | 34 | 37 | 40 | 43 | 44 | 47 | 53 | 57 | 62 | 66 | 69 | 70 | 70 | 75 | 76 | 79 | 80 | 86 | 90 | 95 | 96 | 102 | 105 | 108 | 111 | 107 | 111 | 109 | 106 | 111 | 117 | 114 | 112 |
| Interest | 5 | 7 | 8 | 8 | 8 | 8 | 7 | 8 | 10 | 9 | 7 | 7 | 7 | 7 | 8 | 1 | 9 | 6 | 9 | 12 | 14 | 10 | 11 | 13 | 11 | 13 | 12 | 13 | 12 | 16 | 12 | 13 | 12 | 12 |
| Profit Before Tax | 98 | 104 | 83 | 97 | 107 | 129 | 87 | 170 | 107 | 153 | 66 | 94 | 117 | 192 | 95 | 82 | 128 | 179 | 93 | 130 | 140 | 231 | 123 | 151 | 138 | 209 | 101 | 137 | 181 | 241 | 101 | 85 | 28 | 196 |
| Tax | 16 | 20 | 17 | 19 | 20 | 29 | 15 | 42 | 15 | 33 | 8 | 10 | 14 | 32 | 17 | 16 | 24 | 31 | 19 | 28 | 30 | 52 | 30 | 34 | 27 | 20 | 26 | 31 | 50 | 57 | 15 | 18 | 13 | 48 |
| Net Profit | 82 | 85 | 66 | 78 | 87 | 100 | 72 | 128 | 92 | 120 | 58 | 84 | 102 | 161 | 77 | 67 | 104 | 148 | 74 | 102 | 110 | 179 | 93 | 117 | 112 | 189 | 76 | 106 | 131 | 183 | 87 | 67 | 15 | 148 |
| EPS in ₹ | 4.14 | 4.27 | 3.34 | 3.96 | 2.20 | 2.53 | 1.82 | 3.23 | 2.32 | 3.03 | 1.47 | 2.12 | 2.57 | 4.04 | 1.91 | 1.64 | 2.57 | 3.71 | 1.85 | 2.55 | 2.74 | 4.36 | 2.33 | 2.90 | 2.78 | 4.70 | 1.89 | 2.64 | 3.27 | 4.56 | 2.16 | 1.67 | 0.37 | 3.68 |
Syngene International
Syngene International
461.85
-8.35
(-1.78%)
Market Cap
18,609.76 Cr
PE Ratio
59.83
Volume
4,76,765.00
Day High - Low
472.15 - 460.25
52W High-Low
728.60 - 380.00
Key Fundamentals
Market Cap
18,609.76 Cr
EPS
7.87
PE Ratio
59.83
PB Ratio
3.92
Book Value
120.10
EBITDA
841.90
Dividend Yield
0.27 %
Industry
Healthcare Sector
Healthcare Technology Return on Equity
10.50
Debt to Equity
0.13
Analyst Rating and Forecast
- By Refinitiv from8 analysts
Actual
Company News
View All News
Syngene dividend claim reminder
3 days ago
3 days agoSyngene International reminds shareholders to claim unclaimed dividends for FY 2018-19 onwards by August 21, 2026, to avoid transfer to IEPF.
Syngene Seeks Shareholder nod3 days ago
3 days agoSyngene International seeks approval via postal ballot to appoint Kiran Mazumdar-Shaw as Executive Chairperson with annual remuneration of ₹4 crore.
Syngene International approved the voluntary liquidation of its wholly-owned subsidiary, Syngene Manufacturing Solutions Limited. The subsidiary had no business operations and a net worth of ₹93,97,513. The move will not impact the company's consolidated financials.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
461.85 | #1 18,609.76 | #5 59.83 | #1 3,738.70 | #5 0.66 | #2 324 | #6 -19.31 | 53.36 | |
508.55 | 12,246.29 | #1 30.55 | 3,510.50 | 19.14 | #1 349 | -32.23 | 50.49 | |
265.45 | 7,000.46 | -25.61 | 7.11 | -59.60 | -276 | -3.87 | 75.18 | |
451.55 | 2,017.04 | 35.09 | 322.30 | 0.22 | 41 | 112.87 | 45.20 | |
29.20 | 431.97 | 38.33 | 54.19 | #1 431.27 | 11 | 189.80 | 34.57 | |
81.83 | 163.00 | -79.21 | 47.50 | 17.87 | 0 | #1 2,300.00 | 52.16 | |
64.03 | 150.76 | -3.63 | 806.50 | 4.78 | -56 | 20.99 | 68.63 | |
17.55 | 25.30 | 33.09 | 56.10 | -33.21 | 1 | -88.00 | 23.20 | |
22.70 | 16.13 | -1.05 | 2.10 | -78.57 | -13 | -333.33 | 62.64 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
0.66 %
Net Income Growth
-34.72 %
Cash Flow Change
12.04 %
ROE
-12.35 %
ROCE
-1.05 %
EBITDA Margin (Avg.)
-26.28 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 3,189 | 3,704 | 4,163 | 4,883 | 5,564 | 5,831 | 6,152 | 6,796 | 7,055 |
| Fixed Assets | 1,030 | 1,377 | 2,020 | 2,201 | 2,393 | 2,667 | 2,850 | 2,802 | 4,046 |
| Current Assets | 1,720 | 1,764 | 1,613 | 1,807 | 2,206 | 2,425 | 1,959 | 2,287 | 2,143 |
| Capital Work in Progress | 155 | 274 | 234 | 237 | 346 | 177 | 838 | 1,266 | 1,040 |
| Investments | 158 | 716 | 776 | 702 | 1,034 | 919 | 548 | 647 | 141 |
| Other Assets | 1,846 | 1,337 | 1,133 | 1,743 | 1,791 | 2,069 | 1,916 | 2,081 | 0 |
| Total Equity & Liabilities | 3,189 | 3,704 | 4,163 | 4,883 | 5,564 | 5,831 | 6,152 | 6,796 | 7,055 |
| Current Liabilities | 784 | 1,129 | 1,539 | 1,133 | 1,229 | 1,188 | 1,144 | 1,396 | 1,552 |
| Non Current Liabilities | 685 | 607 | 448 | 929 | 1,037 | 1,025 | 750 | 673 | 663 |
| Total Equity | 1,720 | 1,968 | 2,176 | 2,821 | 3,298 | 3,618 | 4,258 | 4,727 | 4,839 |
| Reserve & Surplus | 1,520 | 1,768 | 1,776 | 2,421 | 2,897 | 3,217 | 3,856 | 4,324 | 4,436 |
| Share Capital | 200 | 200 | 400 | 400 | 401 | 401 | 402 | 403 | 403 |
Cash Flow
| Cash Flow | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 18 | -88 | 28 | 130 | -62 | -172 | -4 | 281 |
| Investing Activities | -349 | -646 | -424 | -629 | -611 | -653 | -495 | -744 |
| Operating Activities | 446 | 630 | 677 | 701 | 581 | 824 | 1,042 | 1,168 |
| Financing Activities | -79 | -72 | -226 | 58 | -31 | -343 | -551 | -142 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 70.58 % | 70.43 % | 70.42 % | 70.41 % | 70.41 % | 70.29 % | 64.86 % | 64.86 % | 54.88 % | 54.80 % | 54.79 % | 54.79 % | 54.79 % | 54.72 % | 54.72 % | 52.74 % | 52.74 % | 52.68 % | 52.68 % | 52.68 % | 52.68 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.02 % | 0.02 % | 0.00 % | 0.00 % | 0.00 % | 20.92 % | 20.63 % | 20.72 % | 20.64 % | 19.47 % | 16.50 % | 16.31 % | 14.96 % | 13.90 % |
| DIIs | 4.02 % | 3.81 % | 4.03 % | 3.64 % | 3.26 % | 2.79 % | 4.96 % | 7.04 % | 10.73 % | 11.20 % | 9.94 % | 13.08 % | 15.80 % | 16.80 % | 17.48 % | 19.53 % | 21.50 % | 24.05 % | 24.62 % | 25.84 % | 26.44 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 8.05 % | 8.29 % | 8.46 % | 9.20 % | 9.22 % | 9.02 % | 8.81 % | 8.57 % | 8.39 % | 8.10 % | 7.53 % | 7.24 % | 6.45 % | 6.08 % | 5.45 % | 5.59 % | 5.08 % | 5.59 % | 5.28 % | 5.37 % | 5.51 % |
| Others | 17.35 % | 17.46 % | 17.09 % | 16.76 % | 17.11 % | 17.90 % | 21.36 % | 19.52 % | 25.98 % | 25.90 % | 27.73 % | 24.89 % | 2.03 % | 1.77 % | 1.62 % | 1.50 % | 1.21 % | 1.18 % | 1.10 % | 1.15 % | 1.46 % |
| No of Share Holders | 1,15,632 | 1,26,395 | 1,36,749 | 1,37,892 | 1,33,610 | 1,28,278 | 1,34,334 | 1,27,964 | 1,24,014 | 1,25,455 | 1,25,992 | 1,21,880 | 1,15,850 | 1,20,018 | 1,07,338 | 1,28,806 | 1,25,090 | 1,42,310 | 1,36,061 | 1,31,750 | 1,35,605 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 1 | 1 | 0.5 | 0.00 | 0.00 | 1 | 1.25 | 1.25 | 1.25 | 0.00 |
| Dividend Yield (%) | 0.33 | 0.34 | 0.21 | 0.00 | 0.00 | 0.17 | 0.18 | 0.17 | 0.32 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 29 Jul 2026 |  Annual General Meeting | NA | 29 Jul 2026 | 440.00 | 461.85 |
| 26 Jun 2026 |  Dividend | ₹ 1.25 /share | 25 Jun 2026 | 440.00 | 461.85 |
| 12 Jun 2019 |  Bonus | 1:1 | 11 Jun 2019 | 340.05 | 336.35 |
| 01 Jul 2022 | Dividend | ₹ 0.50 /share | 30 Jun 2022 | 627.50 | 554.75 |
| 01 Jul 2022 | Dividend | ₹ 0.50 /share | 30 Jun 2022 | 627.50 | 554.75 |
| 30 Jun 2023 | Dividend | ₹ 0.50 /share | 30 Jun 2023 | 625.90 | 759.60 |
| 30 Jun 2023 | Dividend | ₹ 0.75 /share | 30 Jun 2023 | 625.90 | 759.60 |
| 28 Jun 2024 | Dividend | ₹ 1.25 /share | 28 Jun 2024 | 701.05 | 713.15 |
| 24 Jul 2024 | Annual General Meeting | NA | 24 Jul 2024 | 701.05 | 757.75 |
| 23 Oct 2024 |  Quarterly Result Announcement | NA | 23 Oct 2024 | 884.35 | 838.90 |
| 23 Jan 2025 | Quarterly Result Announcement | NA | 23 Jan 2025 | 859.80 | 828.15 |
| 23 Apr 2025 | Quarterly Result Announcement | NA | 23 Apr 2025 | 697.45 | 735.45 |
| 27 Jun 2025 | Dividend | ₹ 1.25 /share | 27 Jun 2025 | 735.45 | 645.85 |
| 23 Jul 2025 | Annual General Meeting | NA | 23 Jul 2025 | 735.45 | 676.25 |
| 23 Jul 2025 | Quarterly Result Announcement | NA | 23 Jul 2025 | 634.20 | 676.25 |
| 05 Nov 2025 | Quarterly Result Announcement | NA | 05 Nov 2025 | 630.65 | 646.55 |
| 22 Jan 2026 | Quarterly Result Announcement | NA | 22 Jan 2026 | 656.75 | 600.85 |
| 29 Apr 2026 | Quarterly Result Announcement | NA | 29 Apr 2026 | 402.95 | 440.00 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication2 days ago
2 days agoReminder Letter To The Shareholders For Claiming Unclaimed Dividends And Updation Of KYC Information.3 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication3 days ago
3 days agoShareholder Meeting / Postal Ballot-Notice of Postal Ballot4 days ago
4 days agoCompliances-Reg.24(A)-Annual Secretarial Compliance5 days ago
5 days agoBoard Meeting Outcome for Outcome Of Board Meeting - Voluntary Liquidation Of Syngene Manufacturing Solutions Limited A Wholly Owned Subsidiary.6 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 04, 2026
May 04, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 01, 2026
May 01, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeApr 30, 2026
Apr 30, 2026Announcement under Regulation 30 (LODR)-Investor PresentationApr 30, 2026
Apr 30, 2026Syngene International Limited Has Informed The Exchange That Record Date For The Purpose Of Dividend Is June 26 2026.Apr 29, 2026
Apr 29, 2026Intimation Of Change In Key Managerial Personnel (KMP) To Determine Materiality Of An Event Or InformationApr 29, 2026
Apr 29, 2026AllotmentApr 29, 2026
Apr 29, 2026Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sApr 29, 2026
Apr 29, 2026Announcement under Regulation 30 (LODR)-Change in ManagementApr 29, 2026
Apr 29, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 29, 2026
Apr 29, 2026Announcement under Regulation 30 (LODR)-Dividend UpdatesApr 29, 2026
Apr 29, 2026Board Meeting Outcome for Syngene International Limited Has Submitted To The Exchange The Financial Results For The Period Ended March 31 2026.Apr 29, 2026
Apr 29, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 22, 2026
Apr 22, 2026Board Meeting Intimation for Considering And Approving The Audited Standalone And Consolidated Financial Results For The Quarter And Year Ending March 31 2026; And To Consider The Recommendation Of Final Dividend If Any.Apr 15, 2026
Apr 15, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Apr 15, 2026
Apr 15, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Apr 10, 2026
Apr 10, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2026
Apr 08, 2026Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 29, 2026
Mar 29, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMar 27, 2026
Mar 27, 2026Closure of Trading WindowMar 27, 2026
Mar 27, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 16, 2026
Mar 16, 2026Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 14, 2026
Mar 14, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 13, 2026
Mar 13, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 11, 2026
Mar 11, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMar 06, 2026
Mar 06, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 20, 2026
Feb 20, 2026Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 18, 2026
Feb 18, 2026Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Feb 17, 2026
Feb 17, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 17, 2026
Feb 17, 2026Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 14, 2026
Feb 14, 2026Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 14, 2026
Feb 14, 2026Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 14, 2026
Feb 14, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 30, 2026
Jan 30, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 29, 2026
Jan 29, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 29, 2026
Jan 29, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 28, 2026
Jan 28, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 24, 2026
Jan 24, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 23, 2026
Jan 23, 2026Announcement under Regulation 30 (LODR)-Investor PresentationJan 23, 2026
Jan 23, 2026Board Comments On Fine Levied By The Exchanges.Jan 22, 2026
Jan 22, 2026Intimation Of Amendment Of Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information (UPSI) Of The Company.Jan 22, 2026
Jan 22, 2026Board Meeting Outcome for Outcome Of The Board Meeting - January 22 2026.Jan 22, 2026
Jan 22, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 22, 2026
Jan 22, 2026Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 53.36
ATR(14)
Less Volatile 19.50
STOCH(9,6)
Neutral 40.43
STOCH RSI(14)
Oversold 18.93
MACD(12,26)
Bearish -1.15
ADX(14)
Strong Trend 36.40
UO(9)
Bearish 39.32
ROC(12)
Uptrend And Accelerating 2.61
WillR(14)
Neutral -56.35
About Syngene International
Syngene International Limited is an integrated research, development, and manufacturing services company headquartered in India. It serves global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. The company operates across four business divisions: Discovery Services, Development Services, Manufacturing Services, and Dedicated Centers. With approximately 6000 scientists, Syngene...more
Listing Date
11 Aug, 2015(10 Years,
43 days)
Website
Chairperson NameKiran Mazumdar Shaw
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
